Cargando…
On the Need to Distinguish between Insulin-Normal and Insulin-Resistant Patients in Testosterone Therapy
Male hypogonadism is a disorder characterized by low levels of the hormone testosterone and patients may also have insulin sensitivity (IS) or insulin resistance (IR), such that they show different clinical complications and different metabolic pathways. In this review, we compare metabonomic differ...
Autor principal: | Zolla, Lello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657366/ https://www.ncbi.nlm.nih.gov/pubmed/36361519 http://dx.doi.org/10.3390/ijms232112730 |
Ejemplares similares
-
Plasma Metabonomics in Insulin-Resistant Hypogonadic Patients Induced by Testosterone Treatment
por: Zolla, Lello, et al.
Publicado: (2022) -
Plasma Metabolomics Profile of “Insulin Sensitive” Male Hypogonadism after Testosterone Replacement Therapy
por: Zolla, Lello, et al.
Publicado: (2022) -
Biomarkers to Be Used for Decision of Treatment of Hypogonadal Men with or without Insulin Resistance
por: Zolla, Lello
Publicado: (2023) -
Testosterone replacement therapy in insulin‐sensitive hypogonadal men restores phosphatidylcholine levels by regulation of arachidonic acid metabolism
por: Fanelli, Giuseppina, et al.
Publicado: (2020) -
Metabolic patterns in insulin-resistant male hypogonadism
por: Gevi, Federica, et al.
Publicado: (2018)